Timed Pediatric Risk of Mortality Scores predict outcomes in pediatric liver transplant recipients

被引:8
|
作者
Carroll, CL
Goodman, DM
Superina, RA
Whitington, PF
Alonso, EM
机构
[1] Childrens Mem Hosp, Dept Pediat, Chicago, IL 60614 USA
[2] Childrens Mem Hosp, Dept Surg, Chicago, IL 60614 USA
[3] Northwestern Univ, Sch Med, Chicago, IL USA
关键词
pediatrics; liver transplantation; Severity of Illness Index; outcome assessment; health resources;
D O I
10.1034/j.1399-3046.2003.00084.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
More reliable methods are needed to identify children at risk for poor outcomes following liver transplantation. The Pediatric Risk of Mortality (PRISM) Score is a physiology-based scoring system used to quantify risk of mortality in pediatric intensive care unit (ICU) populations. We evaluated the PRISM Score as a predictor of outcomes including survival in the pediatric liver transplant (LT) population. We retrospectively reviewed the records of 67 consecutive LTs performed between August 1997 and February 2000 at an urban, tertiary children's hospital in Chicago, IL, USA. Four PRISM Scores were calculated to determine which periods were most meaningful. A Classic PRISM Score was calculated during first 24 h of ICU admission, and three PRISM Scores were timed with the patient's transplant: a pre-LT PRISM Score (24 h prior to transplant whether in ICU or not), a 24-h post-LT PRISM Score and a 48-h post-LT PRISM Score. These PRISM Scores and other predictors including transplant number, UNOS status and PELD Score were compared with outcomes including survival using univariate methods. The pre-LT, the 24- and the 48-h PRISM Score were associated with the post-LT number of ventilated days (p < 0.05), ICU days (p < 0.05) and with 1-yr survival (p < 0.04). The PRISM Scores were not related to the post-LT hospital length of stay (LOS) or to 1-yr re-transplantation. The PELD Score correlated with the post-LT hospital LOS, but was not associated with mortality or with the ICU LOS. A patient's UNOS status and Classic PRISM Score were not associated with any of the outcomes measured. PRISM Scores are valid predictors of outcome including survival in pediatric LT recipients. These findings help to demonstrate the importance in this population of a patient's general physiologic condition and its influence on the overall hospital course and survival.
引用
下载
收藏
页码:289 / 295
页数:7
相关论文
共 50 条
  • [31] Portal fibrosis in pediatric liver transplant recipients
    Peeters, PMJG
    Sieders, E
    Van der Heuvel, M
    Bijleveld, CMA
    de Jong, KP
    Porte, RJ
    Ten Vergert, EM
    Sloof, MJH
    Gouw, ASH
    JOURNAL OF HEPATOLOGY, 2000, 32 : 144 - 144
  • [32] Candida infection in pediatric liver transplant recipients
    Gladdy, RA
    Richardson, SE
    Davies, HD
    Superina, RA
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (01): : 16 - 24
  • [33] Health Utilities in Pediatric Liver Transplant Recipients
    Mohammad, Saeed
    Neighbors, Katie
    Alonso, Estella M.
    HEPATOLOGY, 2013, 58 : 808A - 808A
  • [34] HYPERLIPIDEMIA IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    MASCARENHAS, MR
    LINDNER, MA
    KAMANI, N
    WATKINS, JB
    PEDIATRIC RESEARCH, 1989, 25 (04) : A119 - A119
  • [35] Persistent hyperglycemia in pediatric liver transplant recipients
    Romero, R
    Melde, K
    Pillen, T
    Smallwood, GA
    Heffron, T
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3617 - 3618
  • [36] mTOR inhibitors in pediatric liver transplant recipients
    Dumortier, Jerome
    Couchonnal, Eduardo
    Lacaille, Florence
    Rivet, Christine
    Debray, Dominique
    Boillot, Olivier
    Lachaux, Alain
    Ackermann, Oanez
    Gonzales, Emmanuel
    Wildhaber, Barbara E.
    Jacquemin, Emmanuel
    McLin, Valerie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (04) : 403 - 409
  • [37] Renal function in pediatric liver transplant recipients
    McDiarmid, SV
    TRANSPLANTATION, 2001, 72 (04) : 561 - 562
  • [38] Neurodevelopmental Outcomes in Pediatric Heart Transplant Recipients
    Uzark, Karen
    Spicer, Robert
    Beebe, Dean W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (12): : 1306 - 1311
  • [39] MTOR INHIBITORS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
    Dumortier, J.
    Couchonnal, E.
    Lacaille, F.
    Rivet, C.
    Debray, D.
    Boillot, O.
    Lachaux, A.
    Ackermann, O.
    Gonzales, E.
    Wildhaber, B. E.
    Jacquemin, E.
    Mc Lin, V.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [40] Steroid withdrawal in pediatric liver transplant recipients
    Yoshida, A
    Brady, L
    Cronin, D
    Kelly, S
    Siegel, C
    Woodle, ES
    Millis, JM
    TRANSPLANTATION, 1999, 67 (07) : S180 - S180